The Dividend Cafe - State of the Union: What It Means for Markets and Investors

Episode Date: February 25, 2026

David Bahnsen fills in for Brian Szytel with a Daily Recap recorded shortly before the close as markets trade higher (Dow up ~300, S&P up nearly 1%, Nasdaq up over 1%) and notes upcoming Nvidia earnings. He focuses on economic takeaways from the State of the Union rather than politics, highlighting the lack of new affordability proposals as potentially market-friendly. He says Medicaid drug price controls were reiterated but have little market impact due to low passage odds, and that pharma has largely navigated tariff threats already. He reviews proposals for government-matched quasi-401(k) plans for lower-income Americans, requiring hyperscalers to fund their own power needs, and an unrealistic idea of tariffs replacing income taxes. He supports banning congressional stock trading and notes omissions on credit-card rate caps and 2026 tax-cut reconciliation, while flagging a call to ban institutional ownership of residential real estate. 00:00 Market Snapshot Setup 00:36 State of the Union Focus 01:12 Affordability and Policy Restraint 02:15 Prescription Drugs and Pharma 03:25 New Savings Plan Proposal 03:42 AI Data Centers and Power 04:17 Tariffs and Tax Reality Check 04:45 Congress Stock Trading Ban 05:04 What Wasn't Said and Housing 05:48 Wrap Up and Sign Off Links mentioned in this episode: DividendCafe.com TheBahnsenGroup.com

Welcome to the Dividing Cafe, weekly market commentary focused on dividends in your portfolio and dividends in your understanding of economic life. Well, hello and welcome to the daily recap, Dividendin Cafe. Brian is on a plane today, so I am bringing you the recap myself. This is David Bonson. I'm actually recording a few minutes before the market is closed because I have a meeting starting right after the close. But with just about 15 minutes to go, the Dow is up 300 points, the S&P is up almost 1%. The NASDAX up over 1%. So most areas of the market are up today, and the big news aftermarket will be NVIDIA

announcing their results, and we'll see what happens there. But I'm going to dedicate our quick time today to the State of the Union last night. And at the Daily Recap that is in your inbox, I've gone through. and just sort of bullet point did a lot of the main issues. I don't really have any interest here in recapping the politics of it, the highlights, what probably went well for the president, what may not of, some of the Democrat response moments. All those things are what they are. And everyone's going to have their own different opinions as to what worked and didn't and the sort of theatrics of all those different things for good or for bad. But, you know,

there is some economic takeaways I'm going to focus on. I will say, I think it was a bit of a surprise that there wasn't much said about the affordability issue. But I say that as a positive. You know, I think that the White House's view is that a lot of the things they plan to do to make a dent in this issue are already in place and that they do believe larger than normal tax refunds are coming this year, that that will help. And then, of course, the business incentives in the tax bill from last year. And I think that that probably is the lowest hanging fruit. But, you know, my view is if he had come out last night with a bunch of announcements of policies to address affordability, I suspect they would have been mostly negative. And so just sort of seeing a

governmental position of, we've done what we can, we're going to kind of stay out of the way and let these things play out. I understand some people don't think that's good politics. I don't agree with them, but that's a legitimate view. But I do believe it's better in terms of markets, just to the extent that most likely most intervening things, are likely to do more damage than otherwise, you know, the so-called unintended consequences. On the prescription drug front, he did reiterate his desire for this Medicaid price controls plan, but again, markets don't respond to that because markets are well aware that it has no chance of passing. And I think most of what was done on the prescription drug side with the so-called Trump RX

exchange and the fact that all the big pharma companies avoided tariffs by agreeing to do, some form of manufacturing of the U.S., that's really all baked in. The drug sector had been hit pretty hard last year and then rallied big in the kind of last three or four months of the year, has rallied quite nicely in the first almost two months of this year. So it was pretty much already baked in. I think Big Pharma actually as a sector handled itself much better by sort of ignoring some of the threats and pump fakes and things that were taking place from the HHS

department and then really keeping pretty open communication with the White House on the tariff issue. I think they did a good job managing the sensitivities of all that. The president did announce a new initiative for lower income Americans to get their own kind of quasi-401K plans that would receive matching funds from the federal government. I can't really say what the impact of markets on this is because there isn't a lot of clarity. And so until we get more specificity, we'll see. He did say that he wants hyper-scalers, the big tech companies, building a lot of data center for their own power needs related to ramp up in AI that he plans to tell them that they have to pay for their own power plants, which I can assure you they already were, and that they have to pay for the power that they use. And again, there is some possibility of detail in here that might be a little different than what was already baked in.

but for the most part, I think it's a little bit more political hyperbole in anything else. But I certainly agree with the policy. There was a reference to tariffs maybe one day replacing the income tax system. There's no impact on markets there because it's obviously not something that's ever going to happen. I would point out, for my take, we have the highest tariff rates last year that we've seen in a century. And we collected about $300 billion of taxes. but we spend $7 trillion a year and collect $5.2 trillion of revenue. So no, I don't see this replacing the income tax.

He did call in Congress to pass legislation to ban stock trading from elected members of Congress. It's not really something that has an impact on markets, but I certainly agree it's very long overdue. It's actually mind-numbing to me that it hasn't been done sooner, but I thought it was good for the president to use the state of the union to the Congress to say that. Then I'll close off with what he didn't say. There was no mention at all of the plan for a cap on credit card interest,

and there wasn't any mention, despite reports yesterday that it was going to be in the speech, plans for a reconciliation bill in 2026 to try to pass some additional tax cuts. So if there is additional tax plans coming, we didn't hear about it last night. When I take it as a good thing that some of the other issues were not, particularly addressed. He does say he wants to ask Congress to pass a bill banning institutional ownership of residential real estate. I will be very surprised if they can get the votes for that

to happen. But he reiterated in the speech. So all that to say, not any big, profound changes. You know, again, I'll let others dictate if they thought it was a good speech or not politically. It was certainly a very long speech. I guess it's not unreasonable for me to say that there were some things that were probably helpful for him and some other things that weren't. I mean, that's a pretty middle of the road answer, but I think it's accurate. But, you know, everyone else is going to like what they liked or didn't like what they didn't like. But economically, I think we've hit the major points here. I hope it's been useful for you here in the daily recap. And you'll hear from me again in the Dividend Cafe on Friday. In the meantime, enjoy your Wednesday evening.

Ryan will be back from our Palm Beach office tomorrow Thursday. Take care. The Bonson Group is a group of investment professionals registered with High Tower Securities LLC, member FINRA and SIPC with Hightower Advisors, LLC, a registered investment advisor with the SEC. Securities are offered through Hightower Securities LLC. Advisory services are offered through Hightower Advisors, LLC. This is not an offer to buy ourselves securities. No investor process is free at risk. There is no guarantee that the investment process or investment opportunities referenced

TIRAN will be profitable. Past performance is not indicative of current or future performance and is not a guarantee. The investment opportunities, referenced TIRAN, may not be suitable for all investors. data and information referenced herein are from sources believed to be reliable. Any opinions, news, research, analyses, prices, or other information contained in this research is provided as general market commentary and does not constitute investment or vice. The Bonsor Group in Hightower shall not in any way be liable for claims and make no, express, or implied, representations or warranties as to the accuracy or completeness of the data and other information, or for statements

or errors contained in or omissions from the obtained data and information referenced herein. The data and information are provided as of the date reference. Such data and information are subject to change without notice. This document was created for informational purposes only, that opinions expressed, are solely those of the Bonson Group and do not represent those of Hightower Advisors LSC or any of its affiliates. High Tower advisors do not provide tax or legal advice. This material was not intended or written to be used or presented to any entity as tax advice or tax information. Tax laws vary based on the client's individual circumstances and can change at any time without notice.

Clients are urged to consult their tax or legal advisor for any related questions.